Ovid Therapeutics

+$0.08 (+2.31%) As of 6:10 PM UTC today

Why Robinhood?

You can buy or sell OVID and other stocks, options, and ETFs commission-free!

About OVID

Ovid Therapeutics Inc. Common Stock, also called Ovid Therapeutics, is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders.

CEO
Jeremy Max Levin
Employees
67
Headquarters
New York, New York
Founded
2014

OVID Key Statistics

Market Cap
248.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
636.31K
High Today
$3.66
Low Today
$3.32
Open Price
$3.39
Volume
419.00K
52 Week High
$9.40
52 Week Low
$2.25

OVID Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, Pre-Market

You May Also Like

FYLD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure